Amphastar Pharmaceuticals (AMPH) PT Lowered to $30 at Wells Fargo
Tweet
Share
E-mailGet Alerts AMPH Hot Sheet
Price: $20.89 -0.1%
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 20 | New: 20
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 20 | New: 20
Join SI Premium – FREE
Wells Fargo analyst Benjamin Burnett lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $30.00 (from $34.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Sunac China Holdings Limited (1918:HK) (SCCCF) PT Lowered to HK$0.30 at JPMorgan
- EyePoint Inc. (EYPT) PT Lowered to $8 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
